Similar articles

• Methyldopa.

  Sjoerdsma A. Sjoerdsma A. Br J Clin Pharmacol. 1982 Jan;13(1):45-9. doi: 10.1111/j.1365-2125.1982.tb01335.x. Br J Clin Pharmacol. 1982. PMID: 7066154 Free PMC article. No abstract available.
• Reduction of aromatic L-amino acid decarboxylase protein in rats after chronic administration of alpha-methyldopa.

  Culvenor AJ, Jarrott B. Culvenor AJ, et al. Mol Pharmacol. 1979 Jan;15(1):86-98. Mol Pharmacol. 1979. PMID: 106235 No abstract available.
• Homologs of dopa, alpha-methyldopa, and dopamine as potential cardiovascular drugs.

  Winn M, Rasmussen R, Minard F, Kyncl J, Plotnikoff N. Winn M, et al. J Med Chem. 1975 Apr;18(4):434-7. doi: 10.1021/jm00238a024. J Med Chem. 1975. PMID: 1079053
• Studies on the mode of action of alpha-methyldopa.

  Henning M. Henning M. Acta Physiol Scand Suppl. 1969;322:1-37. Acta Physiol Scand Suppl. 1969. PMID: 4311985 Review. No abstract available.
• [Pharmacology of centrally active antihypertensive agents (author's transl)].

  Ozaki M. Ozaki M. Kokyu To Junkan. 1979 Oct;27(10):1077-86. Kokyu To Junkan. 1979. PMID: 41297 Review. Japanese. No abstract available.